GENELUX Corp (GNLX)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
|---|---|---|---|---|
| Revenue | - | - | - | - |
| Research and development | 4,758 | 4,698 | 4,051 | 4,417 |
| General and administrative | 3,034 | 3,118 | 2,890 | 2,475 |
| Total operating expenses | 7,792 | 7,816 | 6,941 | 6,892 |
| Loss from operations | -7,792 | -7,816 | -6,941 | -6,892 |
| Interest income | 224 | 184 | 474 | 316 |
| Bond accretion income | 112 | 140 | - | - |
| Total other income | 336 | 324 | 474 | 316 |
| Net loss | -7,456 | -7,492 | -6,467 | -6,576 |
| Net unrealized loss on investments | -26 | - | - | - |
| Comprehensive loss | -7,482 | -7,492 | -6,467 | -6,576 |
| Loss per share - basic | -0.2 | -0.21 | -0.19 | -0.22 |
| Loss per share - diluted | -0.2 | -0.21 | -0.19 | -0.22 |
| Weighted-average shares outstanding - basic | 37,946,330 | 34,926,075 | 34,532,355 | 29,689,344 |
| Weighted-average shares outstanding - diluted | 37,946,330 | 34,926,075 | 34,532,355 | 29,689,344 |